Pulse Biosciences Operating Income 2016-2018 | PLSE
Pulse Biosciences operating income from 2016 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Pulse Biosciences Annual Operating Income (Millions of US $) |
|
|---|---|
| 2017 | $-26 |
| 2016 | $-10 |
| 2015 | $-4 |
| Pulse Biosciences Quarterly Operating Income (Millions of US $) |
|
|---|---|
| Q3 2018 | $-11 |
| Q2 2018 | $-9 |
| Q1 2018 | $-9 |
| Q4 2017 | $-9 |
| Q3 2017 | $-8 |
| Q2 2017 | $-6 |
| Q1 2017 | $-3 |
| Q4 2016 | $-3 |
| Q3 2016 | $-3 |
| Q2 2016 | $-2 |
| Q1 2016 | $-2 |
| Q4 2015 | $-2 |
| Q3 2015 | $-1 |
| Q2 2015 | $-1 |
| Q1 2015 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.242B | $0.000B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $96.900B | 22.58 |
| Intuitive Surgical (ISRG) | United States | $61.300B | 60.31 |
| Edwards Lifesciences (EW) | United States | $35.181B | 37.65 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.436B | 14.49 |
| IDEXX Laboratories (IDXX) | United States | $17.360B | 49.58 |
| ABIOMED (ABMD) | United States | $15.139B | 108.78 |
| DexCom (DXCM) | United States | $13.400B | 0.00 |
| Hologic (HOLX) | United States | $12.863B | 19.73 |
| Teleflex (TFX) | United States | $11.842B | 26.88 |
| Varian Medical Systems (VAR) | United States | $11.433B | 28.45 |
| STERIS (STE) | United Kingdom | $9.523B | 25.27 |
| Masimo (MASI) | United States | $6.380B | 41.37 |
| Penumbra (PEN) | United States | $4.856B | 293.19 |
| LivaNova (LIVN) | United Kingdom | $4.430B | 28.43 |
| Globus Medical (GMED) | United States | $4.292B | 26.90 |
| Integra LifeSciences Holdings (IART) | United States | $3.916B | 19.08 |
| Wright Medical Group (WMGI) | Netherlands | $3.577B | 0.00 |
| Cantel Medical (CMD) | United States | $3.231B | 31.87 |
| Inogen (INGN) | United States | $3.117B | 67.28 |
| Integer Holdings (ITGR) | United States | $2.530B | 21.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.433B | 0.00 |
| Glaukos (GKOS) | United States | $2.142B | 0.00 |
| Halyard Health (AVNS) | United States | $2.074B | 18.68 |
| OPKO Health (OPK) | United States | $2.060B | 0.00 |
| Nevro (NVRO) | United States | $1.381B | 0.00 |
| Luminex (LMNX) | United States | $1.175B | 42.50 |
| Natus Medical (BABY) | United States | $1.158B | 24.33 |
| Tactile Systems Technology (TCMD) | United States | $1.148B | 182.76 |
| Pacific Biosciences Of California (PACB) | United States | $1.094B | 0.00 |
| CryoLife (CRY) | United States | $1.045B | 91.23 |
| Orthofix (OFIX) | United States | $0.974B | 28.12 |
| Accelerate Diagnostics (AXDX) | United States | $0.913B | 0.00 |
| Intersect ENT (XENT) | United States | $0.892B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.836B | 49.43 |
| AngioDynamics (ANGO) | United States | $0.778B | 25.23 |
| ViewRay (VRAY) | United States | $0.726B | 0.00 |
| Veracyte (VCYT) | United States | $0.703B | 0.00 |
| AxoGen (AXGN) | United States | $0.620B | 0.00 |
| TransEnterix (TRXC) | United States | $0.571B | 0.00 |
| Si-Bone (SIBN) | United States | $0.486B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.436B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.403B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.381B | 0.00 |
| Sientra (SIEN) | United States | $0.353B | 0.00 |
| Fluidigm (FLDM) | United States | $0.352B | 0.00 |
| Accuray (ARAY) | United States | $0.344B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.336B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.272B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.272B | 42.80 |
| IRadimed (IRMD) | United States | $0.259B | 67.57 |
| Nuvectra (NVTR) | United States | $0.251B | 0.00 |
| Neuronetics (STIM) | United States | $0.243B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.225B | 38.75 |
| Corindus Vascular Robotics (CVRS) | United States | $0.214B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.195B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.159B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.130B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.105B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.103B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.085B | 0.00 |
| EDAP TMS (EDAP) | France | $0.080B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.071B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.070B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.065B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.061B | 0.00 |
| Vermillion (VRML) | United States | $0.059B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.053B | 0.00 |
| Electromed (ELMD) | United States | $0.042B | 20.00 |
| Restoration Robotics (HAIR) | United States | $0.041B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.039B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.036B | 0.00 |
| ConforMIS (CFMS) | United States | $0.033B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.029B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.026B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.024B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.022B | 0.00 |
| Dynatronics (DYNT) | United States | $0.021B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.021B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 11.22 |
| Bioanalytical Systems (BASI) | United States | $0.014B | 67.50 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Avinger (AVGR) | United States | $0.008B | 0.00 |
| InspireMD (NSPR) | Israel | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Amedica (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
